GE Vernova vs SLB
GEV and SLB side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GEV and SLB compare
GE Vernova is the larger company, worth 2.9 times as much as SLB ($228B against $79.8B).
On earnings, GE Vernova is cheaper: it trades at 24.5× trailing earnings, against 26.0× for SLB.
GE Vernova grew revenue faster over the last twelve months (13.0% versus 2.5% for SLB).
GE Vernova keeps more of each dollar of sales as profit, with a net margin of 23.0% compared with 8.5% at SLB.
Both pay dividends: GE Vernova yields 0.17% and SLB 2.2%.
GE Vernova scores higher on the StockData Score (13 against 9 for SLB), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GEV | SLB |
|---|---|---|
| Size and price | ||
| Market cap | $228B | $79.8B |
| Share price | $857.87 | $53.74 |
| Change, 1 year | 48.4% | 45.9% |
| Change, 5 years | – | 60.4% |
| Beta (5Y) | 1.37 | 0.73 |
| Employees | 75K | 109K |
| StockData Score | ||
| Total score | 13 (better) | 9 |
| Valuation score | 2 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 4 (better) | 2 |
| Health score | 2 | 3 (better) |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 24.5× (better) | 26.0× |
| P/S | 5.5× | 2.2× (better) |
| P/B | 19.1× | 3.1× (better) |
| EV/EBITDA | 122× | 12.2× (better) |
| P/FCF | 18.4× | 16.6× (better) |
| FCF yield | 5.4% | 6.0% (better) |
| Fair value | – | $39.80 |
| Margin of safety | – | −35.0% |
| Growth | ||
| Revenue growth (TTM) | 13.0% (better) | 2.5% |
| Revenue growth, 5Y average | – | 8.6% |
| Net income growth (TTM) | 724% (better) | −24.2% |
| EPS growth (TTM) | 745% (better) | −29.1% |
| Profitability | ||
| Gross margin | 20.2% | – |
| Operating margin | 4.3% | – |
| Net margin | 23.0% (better) | 8.5% |
| FCF margin | 30.1% (better) | 13.2% |
| Return on equity | 91.5% (better) | 13.4% |
| Return on invested capital | 135% | – |
| Financial health | ||
| Debt / equity | 0.24 (better) | 0.43 |
| Net debt / EBITDA | −5.71 | 0.98 (better) |
| Current ratio | 0.85 | 1.44 (better) |
| Altman Z-score | 2.68 | 2.95 (better) |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 0.17% | 2.2% (better) |
| Payout ratio | 4.3% | 54.7% |
| Years of dividend growth | 1 | – |
| Buyback yield | 2.4% (better) | 1.5% |
| Shareholder yield | 2.5% | 3.7% (better) |
| Ownership | ||
| Held by institutions | 79.8% | 92.3% |
| Held by insiders | 0.10% | 0.19% |
| Insider net buying, 12 months | −$11.5M (better) | −$25.6M |
| Superinvestors holding | 5 (better) | 1 |
| Short interest, % of float | 2.8% | 4.1% |
Go deeper
- GEV stock overview
- GEV income statement
- GEV valuation and score
- SLB stock overview
- SLB income statement
- SLB valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.